CV6 Therapeutics
PrivateLast Round
Grant
Nov 2, 2022
Total Funding Raised
$3.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CV6 Therapeutics is a biotechnology company that develops small-molecule combination therapies for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CV6 Therapeutics Comparables
Compare CV6 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breakpoint Therapeutics | 85% | |
| FoRx Therapeutics | 83% | |
| Hemispherian AS | 83% |
CV6 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 2, 2022 | ||||
| VC Round | Nov 2, 2022 |
Key People
Founding team and executive leadership
CV6 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | VC Round |
| Invest Northern Ireland | Grant, VC Round |
| Clarendon Fund Managers | VC Round |
| Techstart Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 35% to 2.8K.
- Apr 16, 2026
Monthly visitors increased 32% MoM, reaching 2.3K.
CV6 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CV6 Therapeutics's valuation, stock price, and market status.
Is CV6 Therapeutics a public or private company?
CV6 Therapeutics is a private company.
What is the current stock price of CV6 Therapeutics?
CV6 Therapeutics is a private company with no public stock price. Caplight tracks CV6 Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CV6 Therapeutics worth (valuation)?
Valuation information for CV6 Therapeutics is not publicly available.
Can I buy CV6 Therapeutics stock?
CV6 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CV6 Therapeutics's last funding round?
CV6 Therapeutics's most recent funding round was Grant on November 2, 2022.
Who are the main investors in CV6 Therapeutics?
Key investors in CV6 Therapeutics include QUBIS, Invest Northern Ireland, Clarendon Fund Managers, Techstart Ventures.
Will CV6 Therapeutics IPO soon?
No public IPO plans have been announced for CV6 Therapeutics.
How can I track CV6 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CV6 Therapeutics's secondary market activity and sign up for updates.